King Abdullah International Medical Research Center

King Abdullah International Medical Research Center (KAIMRC) is an international institute of biomedical and clinical research.[1] It was launched on 11 November 2006 with the approval of the Custodian of the Two Holy Mosques, King Abdullah bin Abdulaziz. The center is part of the Ministry of National Guard Health Affairs and is located in Riyadh, Saudi Arabia, with campuses in Jeddah and Al-Ahsa.[2]

King Abdullah International Medical Research Center (KAIMRC)
AbbreviationKAIMRC
Formation11 November 2006
FounderCustodian of the Two Holy Mosques King Abdullah bin Abdul Aziz
Founded atRiyadh, Saudi Arabia
PurposeBiomedical and clinical research
HeadquartersRiyadh, Saudi Arabia
Location
  • Riyadh, Jeddah, Al-Ahsa
Parent organization
Ministry of National Guard Health Affairs
Websitekaimrc.ksau-hs.edu.sa

Achievements

edit

KAIMRC was awarded accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) on July 3, 2023.[3][4] The center has also started a Phase I clinical trial for a vaccine against the Middle East respiratory syndrome coronavirus (MERS-CoV) in collaboration with the Jenner Institute at the University of Oxford.[5]

References

edit
  1. ^ https://kaimrc.ksau-hs.edu.sa/
  2. ^ "King Abdullah International Medical Research Center (KAIMRC)". www.ksau-hs.edu.sa.
  3. ^ "AAHRPP Awards Accreditation to King Abdullah International Medical Research Center (KAIMRC)". Default.
  4. ^ "AAHRPP Awards Accreditation to King Abdullah International Medical Research Center (KAIMRC)". kaimrc.ksau-hs.edu.sa.
  5. ^ Staff Writer; Gazette, Saudi. "Saudi: KAIMRC, Sanofi agree to advance clinical research and build sustainable". www.zawya.com.
edit